Hoya Corp
TSE:7741
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16 050
21 695
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hoya Corp
Hoya Corp
Cash Equivalents
Hoya Corp
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hoya Corp
TSE:7741
|
Cash Equivalents
¥553B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Cash Equivalents
¥22.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Shofu Inc
TSE:7979
|
Cash Equivalents
¥9.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Menicon Co Ltd
TSE:7780
|
Cash Equivalents
¥40.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Mani Inc
TSE:7730
|
Cash Equivalents
¥21.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
|
Nipro Corp
TSE:8086
|
Cash Equivalents
¥83.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
Hoya Corp
Glance View
Hoya Corporation is a diversified multinational company based in Japan, renowned for its innovation and leadership in the optics and healthcare sectors. Established in 1941, Hoya initially made its mark in the manufacturing of optical glass, but over the decades, it has evolved into a powerhouse with a broad portfolio. Today, Hoya operates primarily in two segments: Health Care and Information Technology. The healthcare segment focuses on intraocular lenses and other medical devices, which are critical in the growing field of eye care and surgery. Simultaneously, the IT segment specializes in photomasks, essential for producing semiconductors, a market experiencing an upsurge due to the digital transformation across various industries. Through its commitment to research and development, Hoya has positioned itself as a vital player in several fast-growing markets, making it an attractive prospect for investors looking to capitalize on future technological advancements. As Hoya continues to expand its global footprint, it benefits from the increasing demand for healthcare solutions and advanced technologies. The aging population across many regions presents a significant growth opportunity for its healthcare products, particularly in ophthalmology. Meanwhile, the relentless push for higher computing power fuels demand for Hoya's advanced photomasks in the semiconductor industry. The company’s robust financial performance and efficient management reflected in its consistent revenue growth and profitability underline its resilience, even in turbulent economic times. Investors unfamiliar with Hoya will find a company firmly anchored in two high-potential sectors, underpinned by a strategic vision that prioritizes innovation and sustainability. With strong fundamentals and a clear growth trajectory, Hoya Corporation represents a compelling investment opportunity for those looking to diversify their portfolios in the burgeoning healthcare and technology markets.
See Also
What is Hoya Corp's Cash Equivalents?
Cash Equivalents
553B
JPY
Based on the financial report for Jun 30, 2024, Hoya Corp's Cash Equivalents amounts to 553B JPY.
What is Hoya Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
7%
Over the last year, the Cash Equivalents growth was 21%. The average annual Cash Equivalents growth rates for Hoya Corp have been 17% over the past three years , 15% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
